{"id":"W2765403114","doi":"10.1080/13696998.2018.1539400","title":"Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective","year":2018,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada); McMaster University","funders":"","keywords":"Medicine; Secukinumab; BASDAI; Golimumab; Adalimumab; BASFI; Ankylosing spondylitis; Certolizumab pegol; Etanercept; Infliximab; Population; Cost effectiveness; Discontinuation; Internal medicine; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00249129,0.001286093,0.001275128,0.002297024,0.0009166884,0.002246897,0.001509362,0.000987903,0.004294273],"category_scores_gemma":[0.008426696,0.0005466539,0.002664166,0.003204231,0.0007150944,0.0006411002,0.0007558351,0.001124858,0.0001520398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0676809,"about_ca_system_score_gemma":0.05709313,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9262653,"about_ca_topic_score_gemma":0.888352,"domain_scores_codex":[0.998045,0.0007515148,0.00007134187,0.0001466987,0.0005942705,0.0003911157],"domain_scores_gemma":[0.9975525,0.001036608,0.0002427067,0.00004454136,0.000837139,0.0002864657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.005607827,0.0003399708,0.02757418,0.002685345,0.004796674,0.0004623956,0.0001761683,0.8630278,0.001082299,0.02522664,0.008624915,0.06039588],"study_design_scores_gemma":[0.002499671,0.001270057,0.0532686,0.001115709,0.006627291,0.0004582404,0.0005107278,0.9073396,0.001053605,0.01036278,0.01521903,0.000274733],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8397107,0.06002752,0.01567054,0.01290495,0.0003504284,0.001300998,0.02219193,0.0001869571,0.04765607],"genre_scores_gemma":[0.9858267,0.006207144,0.003962974,0.0003639749,0.00003516068,0.0001251689,0.00191464,0.00002059401,0.001543721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0737347,"threshold_uncertainty_score":0.4910616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03604495381201373,"score_gpt":0.3326350826472689,"score_spread":0.2965901288352552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}